Mayo Clinic IBD Biobank
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT03756649
- Status
- Enrolling By Invitation
Conditions
- Inflammatory Bowel Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- Blood Draw — PROCEDURE50 ml will be collected
- Urine Collection — PROCEDURE50 ml will be collected
- Stool Collection — PROCEDUREThree 25 ml tubes will be collected
Study Details
Researchers are collecting and storing blood, stool, and urine samples and medical information to better understand Inflammatory Bowel Disease (IBD) to improve disease outcome.
Key Dates
- Start date
- Nov 1, 2018
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2065
- Completion
- Dec 31, 2065
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Control GroupSubjects without inflammatory bowel disease (IBD) will have samples collected of blood, urine and stool
- Arm: Inflammatory bowel disease (IBD)Subjects with known inflammatory bowel disease will have samples collected of blood, urine and stool
Primary Outcome Measure
Study Participants [ Time Frame: 50 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site
Related Studies
- Utility of Random Biopsies in Patients With Inflammatory Bowel DiseaseEnrolling By Invitation · Abramson Cancer Center at Penn Medicine · Birmingham, Alabama
- BOOM-IBD2 Pivotal Clinical TrialRecruiting · Boomerang Medical · Folsom, California
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisPHASE2 · Recruiting · Spyre Therapeutics, Inc. · Canoga Park, California
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruiting · University of Chicago · Chicago, Illinois